MedPath
NMPA Approval

Neratinib Maleate Tablets

H20200009

April 27, 2020

Drug Information

马来酸奈拉替尼片

贺俪安

片剂

40mg(按C30H29ClN6O3计)

化学药品

April 27, 2020

April 26, 2025

Company Information

Applicant Company

Puma Biotechnology

10880 Wilshire Blvd., Suite 2150, Los Angeles, CA 90024 United States of America

Manufacturing Company

Nurnberger Strasse 12, Feucht, Bayern 90537 Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸奈拉替尼片 - NMPA 批准文号 | MedPath